Can a cancer vaccine prime the body to better fight liver tumors?
NCT ID NCT07726329
First seen Jul 24, 2026 · Last updated Jul 24, 2026
Summary
This trial tests whether giving a personalized dendritic cell vaccine before a standard liver-directed therapy (TACE) can improve outcomes for people with advanced liver cancer that has not responded to other treatments. The vaccine is made from the patient's own immune cells and trained to recognize their tumor. The study will measure safety, tumor shrinkage, and overall survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a dendritic cell vaccine followed by transcatheter arterial chemoembolization (TACE)
- What this could lead to
- If it works, this combination approach could offer a new treatment option for people with advanced liver cancer who have run out of standard options.
- What could go wrong
- This is a mid-stage trial with 100 participants, so results are not yet proven. The treatment involves two complex procedures and may cause side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chang-Gung Memorial Hospital
Taoyuan, 33357, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Training the immune system to hunt down leftover liver cancer cells
- Can a new drug ST316 shrink Hard-to-Treat tumors?
- Could a genetic marker guide future cancer therapies in taiwan?
- Can a tumor-zapping procedure also wake up the immune system?
- A drug used during liver surgery may cut the risk of major complications — a study puts it to the test
- A machine that keeps donor livers alive outside the body — could it transform transplantation?